1,158 results on '"O’Donnell, Denis E."'
Search Results
2. Abnormal Exertional Breathlessness on Cardiopulmonary Cycle Exercise Testing in Relation to Self-Reported and Physiologic Responses in Chronic Airflow Limitation
3. Impaired Spirometry and COPD Increase the Risk of Cardiovascular Disease: A Canadian Cohort Study
4. Physiological underpinnings of exertional dyspnoea in mild fibrosing interstitial lung disease
5. Comparative measurement properties of constant work rate cycling and the endurance shuttle walking test in COPD: the TORRACTO® clinical trial
6. Impaired Sleep Quality in COPD Is Associated With Exacerbations The CanCOLD Cohort Study
7. Reference values for leg effort during incremental cycle ergometry in non‐trained healthy men and women, aged 19–85
8. V̇/Q̇ Mismatch: A Novel Target for COPD Treatment
9. Using Cardiopulmonary Exercise Testing to Understand Dyspnea and Exercise Intolerance in Respiratory Disease
10. Compensatory responses to increased mechanical abnormalities in COPD during sleep
11. Exercise Intolerance in Untreated OSA: Role of Pulmonary Gas Exchange and Systemic Vascular Abnormalities
12. The physiology and pathophysiology of exercise hyperpnea
13. Beyond Spirometry: Linking Wasted Ventilation to Exertional Dyspnea in the Initial Stages of COPD
14. Physiological Characterization of Preserved Ratio Impaired Spirometry in the CanCOLD Study: Implications for Exertional Dyspnea and Exercise Intolerance
15. Normative Reference Equations for Breathlessness Intensity during Incremental Cardiopulmonary Cycle Exercise Testing
16. Cardiovascular Comorbidity in Chronic Lung Disease: The Role of Cardiopulmonary Exercise Testing
17. Multidimensional breathlessness response to exercise: Impact of COPD and healthy ageing
18. Influence of exertional hypoxemia on cerebral oxygenation in fibrotic interstitial lung disease
19. Elevated exercise ventilation in mild COPD is not linked to enhanced central chemosensitivity
20. Effects of combined tiotropium/olodaterol on inspiratory capacity and exercise endurance in COPD.
21. Inspiratory neural drive and dyspnea in interstitial lung disease: Effect of inhaled fentanyl
22. The Lung Function Laboratory to Assist Clinical Decision-making in Pulmonology: Evolving Challenges to an Old Issue
23. Breathing at Extremes: The Restrictive Consequences of Super- and Super-Super Obesity in Men and Women
24. Physiological and perceptual responses to exercise according to locus of symptom limitation in COPD
25. Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement
26. Impaired Sleep Quality in COPD Is Associated With Exacerbations: The CanCOLD Cohort Study
27. Effects of lung deflation induced by tiotropium/olodaterol on the cardiocirculatory responses to exertion in COPD
28. Dyspnea in COPD: New Mechanistic Insights and Management Implications
29. Cluster Analysis in Patients with GOLD 1 Chronic Obstructive Pulmonary Disease.
30. Prescription Synthetic Oral Cannabinoid use Among Older Adults with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study
31. Integrating the Whole: Cardiopulmonary Exercise Testing
32. Is the Slow Vital Capacity Clinically Useful to Uncover Airflow Limitation in Subjects With Preserved FEV1/FVC Ratio?
33. Psychological distress is related to poor health behaviours in COPD and non-COPD patients: Evidence from the CanCOLD study
34. The continuum of physiological impairment during treadmill walking in patients with mild-to-moderate COPD: patient characterization phase of a randomized clinical trial.
35. The Continuum of Physiological Impairment during Treadmill Walking in Patients with Mild-to-Moderate COPD: Patient Characterization Phase of a Randomized Clinical Trial
36. Late Breaking Abstract - Phenotyping dynamic and "static” lung volumes in COPD: implications for exertional dyspnoea and exercise tolerance
37. Late Breaking Abstract - Systemic Determinants of Exercise Intolerance in Patients with Fibrosing Interstitial Lung Disease and a Severely Impaired DLCO
38. Systemic Determinants of Exercise Intolerance in Patients With Fibrotic Interstitial Lung Disease and Severely Impaired DLCO
39. Cardiovascular Comorbidity in Chronic Lung Disease: The Role of Cardiopulmonary Exercise Testing
40. Systemic vascular dysfunction is associated with emphysema burden in mild COPD
41. The role of the pulmonary function laboratory to assist in disease management: connective tissue diseases.
42. Short-term air pollution exposure and exacerbation events in mild to moderate COPD: a case-crossover study within the CanCOLD cohort
43. The Lancet COPD Commission: broader questions remain
44. Response
45. Impact of LABA/LAMA combination on exercise endurance and lung hyperinflation in COPD: A pair-wise and network meta-analysis
46. Long-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with chronic obstructive pulmonary disease
47. Systemic Determinants of Exercise Intolerance in Patients With Fibrotic Interstitial Lung Disease and Severely Impaired DLCO.
48. Online Data Supplement: Dynamic Ventilatory Reserve During Incremental Exercise: Reference Values and Clinical Validation in Chronic Obstructive Pulmonary Disease.
49. Dynamic Ventilatory Reserve During Incremental Exercise: Reference Values and Clinical Validation in Chronic Obstructive Pulmonary Disease.
50. Heart, lungs, and muscle interplay in worsening activity-related breathlessness in advanced cardiopulmonary disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.